Results: Gamma-variate fitting was able to capture contrast arrival time in the DCE-CT images for all 9 patients. Two of the patients displayed clear tumour enhancement prior to aortal enhancement. For these patients, the percentage of the tumour with acausal enhancement with/without a 2 s allowance was 64%/73% and 37%/54%. The mean and standard deviation of the enhancement time differences between the tumour voxels with acausal enhancement and the aorta with/without a 2 sec allowance were -1.8 s ± 0.6 s/-3.4 s ± 1.1 s, and -1.4 ± 0.6 s/-2.6 ± 1.3 s, for each patient.
Results: Gamma-variate fitting was able to capture contrast arrival time in the DCE-CT images for all 9 patients. Two of the patients displayed clear tumour enhancement prior to aortal enhancement. For these patients, the percentage of the tumour with acausal enhancement with/without a 2 s allowance was 64%/73% and 37%/54%. The mean and standard deviation of the enhancement time differences between the tumour voxels with acausal enhancement and the aorta with/without a 2 sec allowance were -1.8 s ± 0.6 s/-3.4 s ± 1.1 s, and -1.4 ± 0.6 s/-2.6 ± 1.3 s, for each patient.
Conclusion:
Our study found apparent acausal enhancement in lung tumours in relation to the aorta for a subset (22%) of the NSCLC patient population examined. For these patients, gamma-variate fitting was able to determine both the percentage of the tumour with acausal enhancement times and the effective enhancement time difference between the tumour voxels and the aorta. These findings highlight the tumor vascular heterogeneity and warrant new kinetic analysis models to incorporate different tumor enhancement analysis and the selection of an appropriate input function.
EP-1866
Traceable calibration chain of PET/CT scanners for I-124 L. Joulaeizadeh 1 VSL, Ionizing Radiation, Delft, The Netherlands 1 Purpose or Objective: PET scanners are used for several decades in a wide range of diagnostic experiments. In the treatment of thyroid cancer with I-131, quantitative information of a PET scan using I-124 is used to determine the release dose to the tumor and critical organs during the treatment. To guarantee comparison of absolute quantification among institutes, measurements have to come along with uncertainty estimates and have to be traceable (i.e. linked) to international measurement standards. However, despite recent advances, PET/CT calibrations are not traceable to any measurement standard. As a result, scans taken at different scanners are not or hardly comparable with each other.
Material and Methods: VSL (National Metrology Institute in
The Netherlands) maintains and develops the national measurement standards, and is able to supply support to the development of calibration chains and standard measurement protocols, thereby guaranteeing traceability to internationally accepted measurement standards. The purpose of this project is to develop a metrological infrastructure and service for on-site calibration of PET/CT scanners. VSL has the facilities to measure the activity of radionuclide solutions in a secondary level traceable to the primary standard at NPL (National Metrology Institute in UK). In 2012 and 2013 in the context of a large national multicenter trial (19 hospitals), a hospital in The Netherlands has performed non-traceable inter-comparison for I-124.
Traceable measurements to validate concept method have been performed by VSL in 2015 for few scanners in The Netherlands. A cylindrical PMMA phantom including 6 holes to position vials of I-124 has been used. Activities inside the vials have been standardized using the secondary standard at VSL with an uncertainty in the range of 2.5% (k=2). Then the phantom has been measured in different scanners.
Results:
The results show differences between the measured activities in two setups which is typically around 40% for activities around 1 MBq, however goes rapidly high by lowering the activity.
Conclusion: PET/CT calibrations for I-124 are not traceable to any measurement standard. The reason is lack of any calibration chain and protocol. Calibration measurements have been introduced and examined for few PET/CT scanners. The results of these measurements strongly propose the need of traceable calibration chain. 
EP-1867 Dosimetric comparison between jaw tracking and static jaw modes in volumetric-modulated arc therapy Y.T. Hsieh

Material and Methods:
The dose distribution around critical organs close to the tumor in HCC is critical owing to its high fractionation dose in Stereotactic Body Radiation Therapy (SBRT). Varian TrueBeam™ (Varian Medical Systems) system provides the JT technique, which keeps the main jaws of the LINAC dynamically as close as possible to the MLC aperture during dose delivery, hence minimize the leakage and transmission of the MLC and further reduces the dose to the organ at risk (OAR). In order to validate the advantage of OAR dose sparing by using JT technique in SBRT for HCC, treatment plans using JT and nJT techniques were designed for dosimetric comparison. Fifteen HCC patients were selected, all treated with doses of 50 Gy in 5 daily fractions with VMAT using 10 MV FFF beams. The maximum dose rate enabled for FFF beams is 2400 MU/min for 10 MV. Each VMAT plan was individually designed using two full and one partial arcs with collimator rotation of 30 and 330 ˚ to obtain the best adherence to planning objectives for each patient. All dose distributions were computed with the Analytical Anisotropic Algorithm (AAA, version 13.6) implemented in the Eclipse planning system with a calculation grid resolution of 2.5 mm. Planning objectives to target coverage aimed to cover CTV with 100% and PTV with at least 95% of the prescribed dose. The main OARs considered were: spinal cord, kidneys, stomach, duodenum, small bowel, chest wall and liver. JT and nJT Planning were performed with the same objectives constraint while plan optimization and the mean doses of OARs were obtained for plan comparison.
Results: At the same CTV and PTV dose coverage, every comparative result shows that JT plan did lower the dose received by OAR and improve the dose fall-off around the low dose region. The significant OAR dose reduction for the JT plan in this study are as follows: the mean doses to the liver was 130cGy less, the V15 of liver was 100 c.c. smaller, the maximum spinal cord dose was 300 cGy lower, and the mean kidney dose was 200 cGy lower than that in the nJT plan.
Conclusion: JT technique did show superior OARs sparing than nJT plans in HCC. The dose reduction is of clinical importance, especially for high fractionation dose SBRT treatment.
